192 filings
Page 8 of 10
6-K
136 xxm1e
28 Mar 19
Current report (foreign)
7:05am
20-F
f4ixgbxlm533hik9ry
28 Mar 19
Annual report (foreign)
7:03am
6-K
50jp6o01
7 Mar 19
Current report (foreign)
7:03am
6-K
xz4nt
31 Jan 19
Current report (foreign)
8:04am
6-K
5z8qgv1ypxf28dx9laer
22 Jan 19
Condensed Consolidated Interim Financial Statements
8:07am
6-K
qfxf4rp85y11npl7yyj
10 Jan 19
Entera Bio Appoints Gerald M. Ostrov to Board of Directors
7:04am
6-K
eup2uvhby ps
11 Dec 18
Entera Bio and Amgen Enter Strategic Research Collaboration in Inflammatory
7:06am
6-K
bvyohi2b5u7xc2yheak2
8 Nov 18
Current report (foreign)
8:25am
6-K
zi5u8p wr1lmw6agv
2 Oct 18
Current report (foreign)
8:15am
6-K
7eurzdw mk009bed
27 Sep 18
Current report (foreign)
12:00am
S-8
8uxxk7gxtqkk oi
24 Sep 18
Registration of securities for employees
12:00am
6-K
vjc0akjra mzj
21 Sep 18
Current report (foreign)
9:21am
6-K
tbvg89rp tgpejdz4e
23 Aug 18
Current report (foreign)
12:00am
6-K
dduzhriih3fcc2 kzzxi
20 Aug 18
Condensed Consolidated Interim Financial Statements
12:00am
6-K
7wc83
9 Aug 18
Current report (foreign)
12:09pm
424B4
7l4t4n4w
29 Jun 18
Prospectus supplement with pricing info
4:39pm
EFFECT
xdeakmofhunuvu
28 Jun 18
Notice of effectiveness
12:15am
F-1/A
1w27l3uyj48s r22nqy2
26 Jun 18
Registration statement (foreign) (amended)
9:49pm
CERT
9u5m6vsx
26 Jun 18
Certification of approval for exchange listing
2:43pm
CORRESP
8qazj33
26 Jun 18
Correspondence with SEC
12:00am